These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The multiple system effects of diphenylhydantoin (Dilantin). Lindall AW Minn Med; 1969 Feb; 52(2):337-44. PubMed ID: 5764821 [No Abstract] [Full Text] [Related]
26. [Diphenylhydantoin and primary hypothyroidism]. Gilsanz Peral A; Costa Talens P; Gómez Balaguer M Rev Clin Esp; 1986 Nov; 179(8):433-5. PubMed ID: 3562962 [No Abstract] [Full Text] [Related]
27. Monoclonal gammopathy and subsequent multiple myeloma in a patient on chronic diphenylhydantoin therapy. Matzner Y; Polliack A Isr J Med Sci; 1978 Dec; 14(12):1265-7. PubMed ID: 748238 [TBL] [Abstract][Full Text] [Related]
30. Flapping tremor associated with administration of diphenylhydantoin sodium. Gitlin N; Morris HB S Afr Med J; 1976 Aug; 50(3F):1427. PubMed ID: 973155 [No Abstract] [Full Text] [Related]
31. Oral diphenylhydantoin sodium and cardiovascular toxicity. Blumsohn D; Seabrook M S Afr Med J; 1970 Oct; 44(42):1207-8. PubMed ID: 5533643 [No Abstract] [Full Text] [Related]
32. [Chronic active hepatitis caused by diphenylhydantoin]. Riera Velasco JR; Rodrigo Sáez LR; Pérez Alvarez R; González González M Med Clin (Barc); 1986 Jun; 87(5):214. PubMed ID: 3736251 [No Abstract] [Full Text] [Related]
33. [Stevens-Johnson syndrome as an early allergic reaction to diphenylhydantoin]. Marg E Psychiatr Neurol Med Psychol (Leipz); 1976 Jul; 28(7):436-9. PubMed ID: 822436 [TBL] [Abstract][Full Text] [Related]
34. Diphenylhydantoin-induced pure red cell aplasia. Rusia U; Malhotra P; Joshi P J Indian Med Assoc; 2006 Jan; 104(1):34-6. PubMed ID: 16850864 [TBL] [Abstract][Full Text] [Related]
35. [Case of gingival hyperplasia due to diphenylhydantoin]. Bella G; Rossetti B; Greco S; Indelicato F Minerva Stomatol; 1987 May; 36(5):367-71. PubMed ID: 3476825 [No Abstract] [Full Text] [Related]
36. [Gingival hyperplasia in patients taking sodium diphenylhydantoin. Current status]. Charbit Y; Hitzig C; Ciosi P Inf Dent; 1986 Jan 2-9; 68(1-2):19-25. PubMed ID: 3458672 [No Abstract] [Full Text] [Related]
37. Diphenylhydantoin. Its usefulness in clinical disorders of a non-epileptic nature. Discussion on safety. Int J Neuropsychiatry; 1967 Dec; 3():Suppl 2:64-6. PubMed ID: 4870959 [No Abstract] [Full Text] [Related]
38. [Intolerance syndrome in diphenylhydantoin therapy]. Cvetko B Neuropsihijatrija; 1966; 14(1):99-102. PubMed ID: 6003488 [No Abstract] [Full Text] [Related]
39. [A case of diphenylhydantoin induced lymphadenopathy (author's transl)]. Ashizawa T; Oda E; Sakuragawa N; Shibata A; Sekiya M; Nemoto K; Okamura A; Ohnishi Y Rinsho Ketsueki; 1979 Apr; 20(4):393-9. PubMed ID: 449058 [No Abstract] [Full Text] [Related]
40. Possible diphenylhydantoin-induced arrhythmia in hypothyroidism. Fulop M; Widrow DR; Colmers RA; Epstein EJ JAMA; 1966 May; 196(5):454-6. PubMed ID: 5952232 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]